Gildy V. Babiera

14.8k total citations · 1 hit paper
184 papers, 9.4k citations indexed

About

Gildy V. Babiera is a scholar working on Cancer Research, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Gildy V. Babiera has authored 184 papers receiving a total of 9.4k indexed citations (citations by other indexed papers that have themselves been cited), including 155 papers in Cancer Research, 95 papers in Pathology and Forensic Medicine and 76 papers in Surgery. Recurrent topics in Gildy V. Babiera's work include Breast Cancer Treatment Studies (152 papers), Breast Lesions and Carcinomas (93 papers) and Breast Implant and Reconstruction (68 papers). Gildy V. Babiera is often cited by papers focused on Breast Cancer Treatment Studies (152 papers), Breast Lesions and Carcinomas (93 papers) and Breast Implant and Reconstruction (68 papers). Gildy V. Babiera collaborates with scholars based in United States, United Kingdom and Switzerland. Gildy V. Babiera's co-authors include Henry M. Kuerer, Kelly K. Hunt, Funda Meric‐Bernstam, Merrick I. Ross, Isabelle Bedrosian, S. Eva Singletary, Barry W. Feig, Frederick C. Ames, Elizabeth A. Mittendorf and Thomas A. Buchholz and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

In The Last Decade

Gildy V. Babiera

182 papers receiving 9.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection

2016 578 citations Abigail S. Caudle, Savitri Krishnamurthy et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gildy V. Babiera United States	57	7.1k	4.6k	3.6k	3.6k	1.0k	184	9.4k
Mattia Intra Italy	53	8.4k 1.2×	5.4k 1.2×	4.1k 1.1×	3.9k 1.1×	1.2k 1.1×	160	10.7k
Frederick C. Ames United States	55	5.8k 0.8×	3.7k 0.8×	3.2k 0.9×	3.7k 1.0×	959 1.0×	127	8.6k
Beryl McCormick United States	52	6.7k 0.9×	3.5k 0.8×	3.1k 0.9×	3.6k 1.0×	1.6k 1.6×	247	10.3k
Adri C. Voogd Netherlands	49	5.0k 0.7×	2.8k 0.6×	2.3k 0.6×	4.9k 1.4×	1.3k 1.3×	275	8.4k
Michele A. Gadd United States	44	3.6k 0.5×	2.4k 0.5×	2.4k 0.7×	2.4k 0.7×	794 0.8×	131	6.8k
Abram Recht United States	65	10.1k 1.4×	6.2k 1.4×	4.6k 1.3×	6.1k 1.7×	2.2k 2.2×	237	14.6k
Alphonse G. Taghian United States	59	7.0k 1.0×	3.5k 0.8×	3.3k 0.9×	5.2k 1.5×	1.8k 1.8×	268	11.7k
Tari A. King United States	48	5.6k 0.8×	3.0k 0.7×	2.1k 0.6×	3.9k 1.1×	1.4k 1.3×	288	9.4k
Roberto Saccozzi Italy	18	6.1k 0.9×	3.6k 0.8×	2.9k 0.8×	2.7k 0.8×	519 0.5×	28	7.5k
R Zucali Italy	40	5.1k 0.7×	3.9k 0.8×	2.6k 0.7×	3.7k 1.0×	1.4k 1.4×	97	8.4k

Countries citing papers authored by Gildy V. Babiera

Since Specialization

Citations

This map shows the geographic impact of Gildy V. Babiera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gildy V. Babiera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gildy V. Babiera more than expected).

Fields of papers citing papers by Gildy V. Babiera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gildy V. Babiera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gildy V. Babiera. The network helps show where Gildy V. Babiera may publish in the future.

Co-authorship network of co-authors of Gildy V. Babiera

This figure shows the co-authorship network connecting the top 25 collaborators of Gildy V. Babiera. A scholar is included among the top collaborators of Gildy V. Babiera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gildy V. Babiera. Gildy V. Babiera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Moreno, Amy C., Yan Lin, Isabelle Bedrosian, et al.. (2020). Outcomes after Treatment of Metaplastic Versus Other Breast Cancer Subtypes. Journal of Cancer. 11(6). 1341–1350. 38 indexed citations

Weiss, Anna, Heather Lin, Gildy V. Babiera, et al.. (2019). Evolution in practice patterns of axillary management following mastectomy in patients with 1–2 positive sentinel nodes. Breast Cancer Research and Treatment. 176(2). 435–444. 21 indexed citations

Weiss, Anna, Heather Lin, Yu Shen, et al.. (2018). Factors associated with improved outcomes for metastatic inflammatory breast cancer patients. Breast Cancer Research and Treatment. 169(3). 615–623. 14 indexed citations

Harao, Michiko, Marie-Andrée Forget, Jason Roszik, et al.. (2017). 4-1BB–Enhanced Expansion of CD8+ TIL from Triple-Negative Breast Cancer Unveils Mutation-Specific CD8+ T Cells. Cancer Immunology Research. 5(6). 439–445. 49 indexed citations

Tasoulis, Marios Konstantinos, et al.. (2017). Sentinel lymph node biopsy in low risk settings. The American Journal of Surgery. 214(3). 489–494. 2 indexed citations

King, Tari A., Jaclyn P. Lyman, Mithat Gönen, et al.. (2016). Prognostic Impact of 21-Gene Recurrence Score in Patients With Stage IV Breast Cancer: TBCRC 013. Journal of Clinical Oncology. 34(20). 2359–2365. 61 indexed citations

Francis, Ashleigh M., Christine E. Haugen, Min Yi, et al.. (2015). Is Sentinel Lymph Node Dissection Warranted for Patients with a Diagnosis of Ductal Carcinoma In Situ?. Annals of Surgical Oncology. 22(13). 4270–4279. 48 indexed citations

Chagpar, Anees B., et al.. (2015). Variation in metastatic workup for patients with invasive breast cancer. The American Journal of Surgery. 210(6). 1147–1154.e2. 8 indexed citations

Meric‐Bernstam, Funda, Argun Akçakanat, Huiqin Chen, et al.. (2014). Influence of Biospecimen Variables on Proteomic Biomarkers in Breast Cancer. Clinical Cancer Research. 20(14). 3870–3883. 40 indexed citations

10.

Dominici, Laura S., Elizabeth A. Mittendorf, Xumei Wang, et al.. (2012). Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy. Breast Cancer Research. 14(3). R82–R82. 37 indexed citations

11.

Akay, Catherine L., Funda Meric‐Bernstam, Kelly K. Hunt, et al.. (2011). Evaluation of the MD Anderson Prognostic Index for Local-Regional Recurrence After Breast Conserving Therapy in Patients Receiving Neoadjuvant Chemotherapy. Annals of Surgical Oncology. 19(3). 901–907. 39 indexed citations

12.

Leeuwen, Barbara L. van, Kari M. Rosenkranz, Liang Feng, et al.. (2010). The effect of under-treatment of breast cancer in women 80 years of age and older. Critical Reviews in Oncology/Hematology. 79(3). 315–320. 65 indexed citations

13.

Fearmonti, Regina M., Isis Gayed, Isabelle Bedrosian, et al.. (2009). Intra-Individual Comparison of Lymphatic Drainage Patterns Using Subareolar and Peritumoral Isotope Injection for Breast Cancer. Annals of Surgical Oncology. 17(1). 220–227. 1 indexed citations

14.

Oh, Julia, Mark Bonnen, Elesyia D. Outlaw, et al.. (2006). The impact of young age on locoregional recurrence after doxorubicin-based breast conservation therapy in patients 40 years old or younger: How young is “young”?. International Journal of Radiation Oncology*Biology*Physics. 65(5). 1345–1352. 44 indexed citations

15.

Hennessy, Bryan T., Sharon H. Giordano, Kristine Broglio, et al.. (2006). Biphasic metaplastic sarcomatoid carcinoma of the breast. Annals of Oncology. 17(4). 605–613. 165 indexed citations

16.

Symmans, W. Fraser, Gildy V. Babiera, S. Eva Singletary, et al.. (2005). Impact of concurrent proliferative high‐risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast‐conserving therapy. Cancer. 106(1). 42–50. 18 indexed citations

17.

Babiera, Gildy V.. (2005). Surgical considerations for breast-conserving therapy in patients undergoing neoadjuvant chemotherapy for early-stage breast cancer. 8(2). 1 indexed citations

18.

Symmans, W. Fraser, Gildy V. Babiera, S. Eva Singletary, et al.. (2005). The clinical impact of proliferative high-risk lesions presenting concurrently with ductal carcinoma in situ (DCIS) in patients (pts) treated with breast conserving therapy (BCT). Journal of Clinical Oncology. 23(16_suppl). 632–632. 3 indexed citations

19.

Shen, Jeannie, Kelly K. Hunt, Nadeem Q. Mirza, et al.. (2004). Intramammary lymph node metastases are an independent predictor of poor outcome in patients with breast carcinoma. Cancer. 101(6). 1330–1337. 52 indexed citations

20.

Meric, Funda, Nadeem Q. Mirza, Georges Vlastos, et al.. (2003). Positive surgical margins and ipsilateral breast tumor recurrence predict disease‐specific survival after breast‐conserving therapy. Cancer. 97(4). 926–933. 158 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact